Amy Goundry Takes on The Role of Managing Editor for Therapeutic Advances in Cardiovascular Disease
Amy Goundry, Managing Editor at Sage, shared on LinkedIn:
”I’ve recently taken on the role of Managing Editor for Therapeutic Advances in Cardiovascular Disease, a gold open access journal dedicated to advancing clinical care across the full spectrum of cardiac and circulatory conditions.
The journal is shaped by a global community of researchers and clinicians who care about evidence that informs real treatment decisions — from pharmacological innovations to interventional strategies and other therapeutic approaches that move us closer to precision cardiovascular care.
Always glad to connect with researchers and clinicians helping to shape the conversation in cardiovascular care — whether by sharing their research or contributing to the journal’s editorial community!”
Find the Journal here.
Stay updated with Hemostasis Today.
-
Apr 16, 2026, 18:27Are We Underestimating VTE After PanNET Surgery? – RPTH Journal
-
Apr 16, 2026, 16:10Hamid Noori: Etiological Classification of Anemia Understanding the Root Cause
-
Apr 16, 2026, 15:29Sebastian Klapa: Key Findings On Mortality And Cardiovascular Risk In ANCA-Associated Vasculitis
-
Apr 16, 2026, 15:23Ifeanyichukwu Ifechidere: Argatroban – Its ‘Rescue Mission’ in Heparin-Induced Thrombocytopenia
-
Apr 16, 2026, 14:58Early Diagnosis Can Change Everything in Hemophilia Care – WFH
-
Apr 16, 2026, 14:05Saleh Shamse Basha: When Platelet Counts Mislead, The PLT-F Becomes Critical
-
Apr 16, 2026, 13:44Maha Othman: Celebrating National Medical Laboratory Week in Canada
-
Apr 16, 2026, 13:42Megan Adediran: How Much of What You Know About Hemophilia Is True?
-
Apr 16, 2026, 13:35Priya Singh: How to Write the Discussion of a Research Paper